VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $338,339 | -10.6% | 12,573 | 0.0% | 0.18% | +5.3% |
| Q2 2023 | $378,573 | -6.9% | 12,573 | 0.0% | 0.17% | -21.2% |
| Q1 2023 | $406,737 | +12.9% | 12,573 | 0.0% | 0.22% | +14.8% |
| Q4 2022 | $360,342 | +18.9% | 12,573 | 0.0% | 0.19% | +6.2% |
| Q3 2022 | $303,000 | -68.9% | 12,573 | -64.7% | 0.18% | -69.7% |
| Q2 2022 | $974,000 | -28.6% | 35,573 | 0.0% | 0.59% | -12.8% |
| Q1 2022 | $1,364,000 | -22.2% | 35,573 | -35.1% | 0.67% | -8.9% |
| Q4 2021 | $1,754,000 | -23.7% | 54,773 | -29.8% | 0.74% | -24.3% |
| Q3 2021 | $2,300,000 | -11.0% | 78,073 | +2.6% | 0.98% | -18.1% |
| Q2 2021 | $2,585,000 | +1.2% | 76,073 | -3.2% | 1.19% | +0.6% |
| Q1 2021 | $2,554,000 | -17.1% | 78,573 | -8.2% | 1.18% | -15.9% |
| Q4 2020 | $3,082,000 | -2.3% | 85,573 | +6.2% | 1.41% | -15.7% |
| Q3 2020 | $3,155,000 | -26.8% | 80,573 | -31.5% | 1.67% | -27.6% |
| Q2 2020 | $4,312,000 | +36.9% | 117,573 | -14.0% | 2.31% | -1.5% |
| Q1 2020 | $3,149,000 | -40.6% | 136,673 | -24.5% | 2.34% | -8.5% |
| Q4 2019 | $5,302,000 | +51.4% | 181,073 | +38.1% | 2.56% | +23.8% |
| Q3 2019 | $3,501,000 | +52.1% | 131,073 | +45.5% | 2.07% | +59.3% |
| Q2 2019 | $2,302,000 | -49.6% | 90,073 | -55.8% | 1.30% | -38.8% |
| Q1 2019 | $4,567,000 | -54.1% | 203,687 | -56.8% | 2.12% | -30.1% |
| Q4 2018 | $9,951,000 | -9.8% | 471,800 | -20.8% | 3.04% | +26.0% |
| Q3 2018 | $11,034,000 | +23.4% | 595,800 | +48.7% | 2.41% | +8.2% |
| Q2 2018 | $8,942,000 | +12.1% | 400,800 | +10.5% | 2.23% | +10.1% |
| Q1 2018 | $7,974,000 | +6.5% | 362,800 | +12.6% | 2.02% | +25.0% |
| Q4 2017 | $7,490,000 | +119.8% | 322,300 | +117.2% | 1.62% | +107.8% |
| Q3 2017 | $3,408,000 | -14.9% | 148,400 | -18.1% | 0.78% | -13.7% |
| Q2 2017 | $4,003,000 | -10.6% | 181,300 | -7.6% | 0.90% | -9.9% |
| Q1 2017 | $4,477,000 | +25.3% | 196,300 | +14.9% | 1.00% | +3.2% |
| Q4 2016 | $3,573,000 | -10.4% | 170,800 | +13.3% | 0.97% | -12.8% |
| Q3 2016 | $3,986,000 | -44.4% | 150,800 | -41.7% | 1.11% | -49.7% |
| Q2 2016 | $7,171,000 | – | 258,800 | – | 2.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |